Therapeutic Oxygen Carriers (TOCs) have been studied in the past for utilization in resuscitation fluid, treatment of organ ischemia, and as an alternative to red blood cell transfusion. One TOC, Hemarina-M101, seems promising in transplantation and oxygenation due its capability as a non-immunogenic, nontoxic, high-oxygen-carrying capacity TOC with little to no side effects. This mini-review focuses on Hemarina-M101 and explores its characteristics and possible utilities through past and recent studies.
Keywords: Arenicola marina; Hemarina-M101; Hemoglobin-based artificial oxygen carriers; TOCs; Therapeutic oxygen carriers.
Copyright © 2020. Published by Elsevier Ltd.